Arrowhead Pharmaceuticals
ARWR
#1968
Rank
โ‚น993.94 B
Marketcap
โ‚น7,098
Share price
1.81%
Change (1 day)
500.67%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): โ‚น30.11

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is โ‚น33.21. an increase over its 2024 EPS that were of -โ‚น474.40.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025-โ‚น0.95-99.8%
2024-โ‚น474.40161.39%
2023-โ‚น181.4917.36%
2022-โ‚น154.6519.85%
2021-โ‚น129.0461.9%
2020-โ‚น79.70-216.67%
2019โ‚น68.31-210.77%
2018-โ‚น61.6738.3%
2017-โ‚น44.59-64.93%
2016-โ‚น127.14-16.25%
2015-โ‚น151.8128%
2014-โ‚น118.60-3.85%
2013-โ‚น123.34-31.58%
2012-โ‚น180.27331.82%
2011-โ‚น41.75-51.11%
2010-โ‚น85.39-79.07%
2009-โ‚น407.98-37.68%
2008-โ‚น654.67-16.87%
2007-โ‚น787.5038.33%
2006-โ‚น569.28122.22%
2005-โ‚น256.1842.11%
2004-โ‚น180.27533.33%
2003-โ‚น28.46-99.08%
2002-โ‚น3,08125%
2001-โ‚น2,46433.33%
2000-โ‚น1,848-120%
1999โ‚น9,242-400%
1998-โ‚น3,081-81.48%
1997-โ‚น16,635

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,057 3,082.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-โ‚น689.78-2,177.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น597.74 1,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น170.78 414.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-โ‚น273.25-922.86%๐Ÿ‡บ๐Ÿ‡ธ USA